Windtree Therapeutics Inc (WINT)
0.4961
-0.01
(-2.59%)
USD |
NASDAQ |
Nov 22, 15:04
Windtree Therapeutics Total Liabilities (Quarterly): 25.21M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 25.21M |
March 31, 2024 | 14.68M |
December 31, 2023 | 29.02M |
September 30, 2023 | 28.57M |
June 30, 2023 | 28.97M |
March 31, 2023 | 28.16M |
December 31, 2022 | 27.94M |
September 30, 2022 | 30.68M |
June 30, 2022 | 32.62M |
March 31, 2022 | 32.38M |
December 31, 2021 | 32.91M |
September 30, 2021 | 34.65M |
June 30, 2021 | 34.10M |
March 31, 2021 | 44.40M |
December 31, 2020 | 43.33M |
September 30, 2020 | 42.81M |
June 30, 2020 | 44.87M |
March 31, 2020 | 42.90M |
December 31, 2019 | 44.04M |
September 30, 2019 | 47.56M |
June 30, 2019 | 46.98M |
March 31, 2019 | 48.63M |
December 31, 2018 | 51.28M |
September 30, 2018 | 33.28M |
June 30, 2018 | 30.36M |
Date | Value |
---|---|
March 31, 2018 | 31.03M |
December 31, 2017 | 27.27M |
September 30, 2017 | 42.10M |
June 30, 2017 | 38.01M |
March 31, 2017 | 37.47M |
December 31, 2016 | 38.53M |
September 30, 2016 | 39.28M |
June 30, 2016 | 40.22M |
March 31, 2016 | 39.69M |
December 31, 2015 | 36.11M |
September 30, 2015 | 34.84M |
June 30, 2015 | 31.28M |
March 31, 2015 | 30.31M |
December 31, 2014 | 28.30M |
September 30, 2014 | 29.34M |
June 30, 2014 | 30.27M |
March 31, 2014 | 30.69M |
December 31, 2013 | 30.82M |
September 30, 2013 | 18.16M |
June 30, 2013 | 17.09M |
March 31, 2013 | 19.70M |
December 31, 2012 | 12.29M |
September 30, 2012 | 16.70M |
June 30, 2012 | 13.48M |
March 31, 2012 | 15.50M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
14.68M
Minimum
Mar 2024
44.87M
Maximum
Jun 2020
33.80M
Average
32.62M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
ANI Pharmaceuticals Inc | 856.58M |
AIM ImmunoTech Inc | 10.68M |
Perspective Therapeutics Inc | 62.68M |
Protalix BioTherapeutics Inc | 29.13M |
Armata Pharmaceuticals Inc | 149.21M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 28.71M |
Shareholders Equity (Quarterly) | 3.494M |